Invention Grant
- Patent Title: Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
-
Application No.: US16658937Application Date: 2019-10-21
-
Publication No.: US11079384B2Publication Date: 2021-08-03
- Inventor: Sean J. Mulvihill , Matthew A. Firpo
- Applicant: University of Utah Research Foundation
- Applicant Address: US UT Salt Lake City
- Assignee: University of Utah Research Foundation
- Current Assignee: University of Utah Research Foundation
- Current Assignee Address: US UT Salt Lake City
- Agency: Ballard Spahr LLP
- Main IPC: G01N33/574
- IPC: G01N33/574 ; C12N15/113

Abstract:
The present invention provides biomarker compositions and methods for the diagnosis and prognosis of PDAC. In a particular embodiment, the invention provides methods and compositions for screening, diagnosis and prognosis of early stage, asymptomatic PDAC.
Public/Granted literature
- US20200088733A1 BIOMARKERS AND METHODS FOR DIAGNOSIS OF EARLY STAGE PANCREATIC DUCTAL ADENOCARCINOMA Public/Granted day:2020-03-19
Information query
IPC分类: